Silexion Therapeutics (SLXN) EPS (Basic) (2023 - 2026)
Silexion Therapeutics (SLXN) posted quarterly EPS (Basic) of -$8.46 for Q1 2026, up 77.96% year-over-year from -$4.75 in Q1 2025, and up 74.51% quarter-over-quarter from -$33.18 in Q4 2025.
Silexion Therapeutics (SLXN) EPS (Basic) (2023 - 2026) Analysis & Trends
Silexion Therapeutics' EPS (Basic) history runs 4 years deep, the most recent figure standing at -$8.46 for Q1 2026.
- In Q1 2026, EPS (Basic) rose 77.96% year-over-year to -$8.46; the TTM figure through Mar 2026 stood at -$39.96 (up 86.98% YoY), while the FY2025 annual figure was -$89.6, up 97.74% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$8.46, up from -$33.18 in the prior quarter.
- The five-year high for EPS (Basic) was $8839.6 in Q2 2023, with the low at -$2747.3 in Q3 2024.
- The 4-year median for EPS (Basic) is -$40.79 (2025), against an average of $681.93.
- The sharpest annual moves came in 2024 and 2025: EPS (Basic) slumped 152.99% in 2024, then surged 98.95% in 2025.
- Silexion Therapeutics' EPS (Basic) stood at -$2255.0 in 2023, then jumped by 81.37% to -$420.05 in 2024, then surged by 92.1% to -$33.18 in 2025, then jumped by 74.51% to -$8.46 in 2026.
- Business Quant data shows SLXN's EPS (Basic) at -$8.46 in Q1 2026, -$33.18 in Q4 2025, and -$28.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Silexion Therapeutics | 266,692.97 | -1.96 Mn | - | -5.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.17 |
| Mar 31, 2026 | -8.46 |
| Dec 31, 2025 | -33.18 |
| Sep 30, 2025 | -28.80 |
| Jun 30, 2025 | -43.19 |
| Mar 31, 2025 | -38.39 |
| Dec 31, 2024 | -420.05 |
| Sep 30, 2024 | -2,747.28 |
| Jun 30, 2024 | 7,913.98 |
| Mar 31, 2024 | -1,910.07 |
| Dec 31, 2023 | -2,255.03 |
| Sep 30, 2023 | -1,085.91 |
| Jun 30, 2023 | 8,839.57 |